日期: 2026-06-10
代码: 2616.HK
事件: 股东增减持（股东增减持）
Li Wei于2026-06-10增持5万股，每股均价4.4港元，最新持股数目205万股，最新持股比例0.13% @#$ Purchase of shares by Dr. Li Wei in the open market using his personal funds. Box 28: Restricted share units and share options granted by CStone Pharmaceuticals pursuant to the Post-IPO RSU Scheme and the Post-IPO ESOP Scheme.